Alume Biosciences Gains FDA Breakthrough Therapy Designation for Bevonescein
SAN DIEGO, Calif. — September 25, 2026 Alume Biosciences, Inc. announced that the U.S. Food and Drug Administration (FDA)...
intraoperative imaging
Advertisement
Lumicell Expands LumiSystem Use in Breast Cancer Surgery Now
Waltham, Massachusetts, U.S., September 15, 2026 Lumicell, Inc. is expanding the commercial use of LumiSystem®, its fluorescence-guided imaging platform...
FDA Seeks Input to Advance Botanical Drug Development
Silver Spring, Maryland, USA, September 3, 2026 The U.S. Food and Drug Administration (FDA) has issued a Request for...
AbbVie Completes $10.9 Billion Apogee Acquisition
North Chicago, Illinois, USA, September 3, 2026 AbbVie has completed its acquisition of Apogee Therapeutics, strengthening the pharmaceutical company’s...
Acepodia Gains FDA IND Clearance for ACE723 ADC
Alameda, California, USA, September 4, 2026 Acepodia has announced that the U.S. Food and Drug Administration (FDA) has cleared...
Advertisements
Globus Medical Gains CE Mark for Excelsius3D Imaging
Audubon, Pennsylvania, USA, September 3, 2026 Globus Medical has announced that its Excelsius3D™ Imaging System has received the CE...
Vergent Begins Phase 3 Trial for Lung Imaging Drug
MINNEAPOLIS, Minn., March 17, 2026 Vergent Bioscience has announced the initiation of its Phase 3 VISUALIZE 2 pivotal clinical...
FDA Clears First Nerve-Specific Imaging Agent for Surgery
PORTLAND, Ore., Jan. 31, 2026 — Trace Biosciences announced that the U.S. Food and Drug Administration (FDA) has granted...
Advertisement
